Dennis L. Winger, Director at Pacira Pharmaceuticals, Inc. (PCRX), bought 2,645 shares at $94.54 ($250K) on 2014-12-05, disclosed to the SEC on 2014-12-08.
Open-market purchase of $250k PCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ARAY | BUY | 2013-03-05 | $86K | — | Filing → |
| NKTR | BUY | 2012-09-18 | $46K | — | Filing → |
| VRTX | BUY | 2010-02-18 | $251K | — | Filing → |